← All tickers

Is OPK Worth Buying in 2026?

Opko Health Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.13% over 10 days); RSI 58 — healthy momentum range; 3-month momentum positive (+25.4%). Concerns: declining volume on rally — weak conviction (0.67x 30d avg). Currently 20.2% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

OPK is in a confirmed uptrend, trading above both its 50-day ($1.38) and 200-day ($1.28) moving averages. An RSI of 57.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +2.2% compares to +20.4% for SPY (trailed the market by 18.1%). The current 20.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,222 today
vs. S&P 500 (SPY) — same period trailed market by 18.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.28)
✓Above 50-day MA ($1.38)
✓RSI(14) neutral zone (30–70) — currently 57.6
✓Positive return (+2.2%)
!Within 10% of period high (−20.2%)
Period Range $1.38
$0.98 $1.73
RSI (14) 57.6
0 · OversoldOverbought · 100

Key Metrics

Price$1.38
Period Return+2.2%
Period High$1.73
Period Low$0.98
Drawdown−20.2%
MA-50$1.38
MA-200$1.28
RSI (14)57.6
Avg Volume (30d)4.1M
vs. SPYtrailed by 18.1%
Return Rank#665 of 1252

Trade OPK

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers